Researchers Say Monthly Injections Of Long-Acting Cabotegravir Plus Rilpivirine Was Non-Inferior To Daily Oral Therapy For Maintaining HIV-1 Suppression

Infectious Disease Advisor (3/23, Gupta) reports researchers found in two trials, FLAIR1 and ATLAS2, that treatment “with monthly injections of long-acting cabotegravir plus rilpivirine was noninferior to once-daily oral therapy for maintaining HIV-1 supp...